Thank you for your interest in a career at Senti Biosciences. We are seeking individuals who are passionate about the future of genetic circuit therapeutics and have the energy and boldness to thrive and grow in a dynamic and fast entrepreneurial environment.
Senti Biosciences is searching for a full-time Strategy & Business Development (BD) Analyst who will help support the BD function. The role will require the Analyst to think through and develop a deep understanding of strategic issues relating to existing and new drug development programs. Analytical work for this role may encompass primary and secondary market research within one or more of the following areas: scientific/technical background, current standard of care, clinical pipeline, commercial/competitive landscape, M&A activity, and partnership opportunities. The Analyst will have the opportunity to regularly interact with and communicate the results of such research findings to Senti’s leadership team. The Analyst will also help to create highly polished internal company reports and external presentations, as well as track the company’s interactions with potential investors and partners.
Senti Bio is the next generation therapeutics company that designs gene circuits and programs cells for tremendous therapeutic value. Our mission is to engineer an entirely new class of medicine that will transform people’s lives by curing the most challenging diseases. We are proud to count NEA, 8VC, Amgen Ventures, Pear Ventures, Lux Capital, Menlo Ventures, Allen & Company, Nest.Bio
, Omega Funds, Goodman Capital, and LifeForce Capital among their investors. Senti Bio is based in South San Francisco, CA, USA.